JP2022530192A5 - - Google Patents

Info

Publication number
JP2022530192A5
JP2022530192A5 JP2021560095A JP2021560095A JP2022530192A5 JP 2022530192 A5 JP2022530192 A5 JP 2022530192A5 JP 2021560095 A JP2021560095 A JP 2021560095A JP 2021560095 A JP2021560095 A JP 2021560095A JP 2022530192 A5 JP2022530192 A5 JP 2022530192A5
Authority
JP
Japan
Prior art keywords
plasmid
helper
gene
functional
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021560095A
Other languages
English (en)
Japanese (ja)
Other versions
JP7562558B2 (ja
JP2022530192A (ja
Filing date
Publication date
Priority claimed from GBGB1905263.8A external-priority patent/GB201905263D0/en
Priority claimed from EP19169121.1A external-priority patent/EP3722434B2/en
Application filed filed Critical
Priority claimed from PCT/GB2020/050947 external-priority patent/WO2020208379A1/en
Publication of JP2022530192A publication Critical patent/JP2022530192A/ja
Publication of JP2022530192A5 publication Critical patent/JP2022530192A5/ja
Application granted granted Critical
Publication of JP7562558B2 publication Critical patent/JP7562558B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021560095A 2019-04-12 2020-04-14 プラスミドシステム Active JP7562558B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP19169121.1 2019-04-12
GBGB1905263.8A GB201905263D0 (en) 2019-04-12 2019-04-12 Plasmid system
EP19169121.1A EP3722434B2 (en) 2019-04-12 2019-04-12 Plasmid system
GB1905263.8 2019-04-12
PCT/GB2020/050947 WO2020208379A1 (en) 2019-04-12 2020-04-14 Plasmid system

Publications (3)

Publication Number Publication Date
JP2022530192A JP2022530192A (ja) 2022-06-28
JP2022530192A5 true JP2022530192A5 (cg-RX-API-DMAC7.html) 2023-04-17
JP7562558B2 JP7562558B2 (ja) 2024-10-07

Family

ID=70295566

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021560095A Active JP7562558B2 (ja) 2019-04-12 2020-04-14 プラスミドシステム

Country Status (11)

Country Link
US (2) US20220162642A1 (cg-RX-API-DMAC7.html)
EP (1) EP3953482A1 (cg-RX-API-DMAC7.html)
JP (1) JP7562558B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220019669A (cg-RX-API-DMAC7.html)
CN (1) CN113891942A (cg-RX-API-DMAC7.html)
AU (1) AU2020272557B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021020401A2 (cg-RX-API-DMAC7.html)
CA (1) CA3136545A1 (cg-RX-API-DMAC7.html)
IL (2) IL296544A (cg-RX-API-DMAC7.html)
SG (1) SG11202111149VA (cg-RX-API-DMAC7.html)
WO (1) WO2020208379A1 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020001593A (es) 2017-08-09 2020-07-13 Bioverativ Therapeutics Inc Moleculas de acido nucleico y usos de las mismas.
JP7602454B2 (ja) 2018-08-09 2024-12-18 バイオベラティブ セラピューティクス インコーポレイテッド 核酸分子及び非ウイルス遺伝子治療のためのそれらの使用
PL3722434T3 (pl) 2019-04-12 2022-12-12 Freeline Therapeutics Limited Układ plazmidowy
WO2021084276A2 (en) 2019-11-01 2021-05-06 Freeline Therapeutics Limited Factor viii construct
WO2022159702A1 (en) * 2021-01-22 2022-07-28 Biogen Ma Inc. Microtubule destabilizer additives to increase recombinant viral vector titers
WO2022182986A1 (en) * 2021-02-26 2022-09-01 Logicbio Therapeutics, Inc. Manufacturing and use of recombinant aav vectors
EP4410971A4 (en) * 2021-09-30 2025-06-04 FUJIFILM Corporation METHOD FOR PRODUCING AN ADENO-ASSOCIATED VIRUS, CELLS AND EXPRESSION VECTOR
GB202214328D0 (en) 2022-09-29 2022-11-16 Freeline Therapeutics Ltd Method
WO2024160232A1 (zh) * 2023-02-01 2024-08-08 纽福斯(苏州)生物科技有限公司 质粒包装系统及其应用
CN118633572B (zh) * 2023-03-06 2026-07-21 北京锦篮基因科技股份有限公司 神经元核内包涵体病小鼠模型构建方法及应用
WO2024223931A1 (en) * 2023-04-28 2024-10-31 AstraZeneca Ireland Limited Manufacturing and use of recombinant self-complementary aav vectors
KR20260082361A (ko) 2023-08-31 2026-06-04 디노 테라퓨틱스, 인코포레이티드 캡시드 폴리펩타이드 및 이의 사용 방법
WO2025083617A1 (en) * 2023-10-18 2025-04-24 Nanocell Therapeutics Holdings B.V. Methods and compositions for nucleic construct delivery
TW202545971A (zh) 2024-02-08 2025-12-01 美商戴諾治療公司 殼體多肽及其使用方法
TW202548023A (zh) 2024-03-14 2025-12-16 美商雅菲納治療公司 用於生產重組腺相關病毒的質體系統
EP4628576A1 (en) 2024-04-07 2025-10-08 Ascend Advanced Therapies GmbH Microrna molecules for use in methods for improving recombinant aav production
WO2025238067A1 (en) 2024-05-15 2025-11-20 Ascend Advanced Therapies Gmbh Novel vector system for aav production
EP4752226A1 (en) 2024-11-28 2026-06-03 Ascend Advanced Therapies GmbH Plasmid system for aav production
WO2026064428A2 (en) 2024-09-18 2026-03-26 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof
WO2026064444A1 (en) 2024-09-18 2026-03-26 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof
WO2026064442A2 (en) 2024-09-18 2026-03-26 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof
WO2026109693A1 (en) 2024-11-21 2026-05-28 Ascend Advanced Therapies Ltd Method for improved aav production
WO2026122963A1 (en) 2024-12-06 2026-06-11 Dyno Therapeutics, Inc. Capsid polypeptides and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10066104A1 (de) 2000-09-08 2003-01-09 Medigene Ag Wirtszellen zur Verpackung von rekombinantem Adeno-assoziiertem Virus (rAAV), Verfahren zu ihrer Herstellung und deren Verwendung
CA2453405A1 (en) * 2001-07-13 2003-01-23 University Of Iowa Research Foundation Pseudotyped adeno-associated viruses and uses thereof
AU2002352195A1 (en) * 2001-11-30 2003-06-10 Medigene Aktiengesellschaft Optimized production of viral vectors derived from paroviruses in packaging and production cells by hsv infection or treatment with dna methylation inhibitors
ES2330826B1 (es) * 2008-06-04 2010-07-26 Proyecto De Biomedicina Cima, S.L. Sistema para empaquetamiento de adenovirus de alta capacidad.
CA2754335C (en) * 2009-03-04 2019-12-24 Medigene Ag Assembly activating protein (aap) and its use for the manufacture of parvovirus particles essentially consisting of vp3
EP3795581A3 (en) 2011-08-24 2021-06-09 The Board of Trustees of the Leland Stanford Junior University New avv capsid proteins for nucleic acid transfer
EP2782596A4 (en) 2011-11-22 2015-07-29 Philadelphia Children Hospital VIRUS VECTORS FOR HIGHLY EFFICIENT TRANSGENIC ADMINISTRATION
GB201420139D0 (en) 2014-11-12 2014-12-24 Ucl Business Plc Factor IX gene therapy
GB201508026D0 (en) 2015-05-11 2015-06-24 Ucl Business Plc Capsid
WO2017096164A1 (en) 2015-12-02 2017-06-08 The Board Of Trustees Of The Leland Stanford Junior University Novel recombinant adeno-associated virus capsids with enhanced human skeletal muscle tropism
CN108048483B (zh) * 2018-01-30 2021-02-02 中国疾病预防控制中心病毒病预防控制所 复制型重组腺病毒HAdV-5载体系统及其应用

Similar Documents

Publication Publication Date Title
JP7796702B2 (ja) スペーサーを含む核酸分子およびその使用の方法
JP2022530544A5 (cg-RX-API-DMAC7.html)
JP6174318B2 (ja) アデノ随伴ウイルス構築物を含んでなるコンダクティング気道細胞を標的とするための組成物
Grieger et al. Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications
JP2022530656A5 (cg-RX-API-DMAC7.html)
US7220577B2 (en) Modified AAV
US8409842B2 (en) Recombinant adeno-associated virus production
JP2021515548A5 (cg-RX-API-DMAC7.html)
JP2018108113A5 (cg-RX-API-DMAC7.html)
CA2303768A1 (en) Methods and vector constructs useful for production of recombinant aav
CA2349838A1 (en) Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
US20250236888A1 (en) Recombinant parvoviral vectors and method of making and use thereof
JP2001512674A (ja) 組換えaavの生産効率を増強する方法
GB2592752A (en) DNA amplification method
CA3218360A1 (en) System for high-level raav production
CN119487183A (zh) 用于生产重组细小病毒的组合物和方法
JP2025516599A5 (cg-RX-API-DMAC7.html)
JPWO2023214579A5 (cg-RX-API-DMAC7.html)
Smith et al. Transposase-mediated construction of an integrated adeno-associated virus type 5 helper plasmid
JP2024519175A5 (cg-RX-API-DMAC7.html)
CN119842817A (zh) 一种用于生产重组腺相关病毒的新型辅助质粒及其构建方法和应用
US7148341B2 (en) AAV DNA comprising helper virus sequences
CN119569834A (zh) 靶向心肌细胞的aav衣壳蛋白变体及其用途
CN114736928A (zh) 一种杆状病毒载体及其在昆虫细胞中制备rAAV的应用
JP2024546578A5 (cg-RX-API-DMAC7.html)